|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/15/2009 8:52:04 AM
MONTVALE, N.J., Jan. 15, 2009 (GLOBE NEWSWIRE) -- Ivivi Technologies, Inc. (Nasdaq:IVVI), a leader in non-invasive, electrotherapy systems, today announced that previously announced results from a double-blind, randomized, placebo-controlled and prospective clinical trial on "no-option" cardiac patients utilizing the Company's proprietary targeted pulsed electromagnetic field (tPEMF(tm)) technology have been peer reviewed and accepted for presentation at the American College of Cardiology (ACC) 58th Annual Scientific Meeting, March 29-31, 2009 in Orlando, Florida.
|
|
|
|
|
|
|
|
|
|
|